Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.69 |
| ▸ | HTT | P42858 | 2/20 | 0.67 |
| ▸ | USP2 | O75604 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | GAA | P10253 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | PPARG | P37231 | 1/20 | 0.59 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.59 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31715997 | 0.98 | KDM4E (0.67) | KDM4EHTTUSP2LMNASMN1; SMN2 | |
| SCHEMBL5781546 | 0.93 | KDM4E (0.61) | KDM4EHTTUSP2LMNASMN1; SMN2 | |
| SCHEMBL1613027 | 0.87 | KDM4E (0.67) | KDM4EHTTUSP2SMN1; SMN2MAPT | |
| SCHEMBL11506441 | 0.87 | KDM4E (0.67) | KDM4EHTTUSP2SMN1; SMN2MAPT | |
| SCHEMBL13209738 | 0.86 | KDM4E (0.69) | KDM4EHTTUSP2SMN1; SMN2MAPT | |
| SCHEMBL6457986 | 0.86 | KDM4E (0.65) | KDM4EHTTUSP2SMN1; SMN2MAPT | |
| SCHEMBL31716523 | 0.82 | ALDH1A1 (0.53) | KDM4EHTTUSP2SMN1; SMN2ALDH1A1 | |
| SCHEMBL31435202 | 0.82 | HTT (0.71) | KDM4EHTTUSP2MAPTGAA | |
| SCHEMBL28535854 | 0.82 | KDM4E (0.64) | KDM4EHTTUSP2MAPTGAA | |
| SCHEMBL2537845 | 0.82 | KDM4E (0.64) | KDM4EHTTUSP2SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240324255-A1 | SOLAR CELL | PANASONIC HOLDINGS CORPORATION (JP) | 2024-09-26 | — | — | US | claimed |
| WO-2023106042-A1 | SOLAR CELL | パナソニックホールディングス株式会社 | 2023-06-15 | — | — | WO | claimed |
| CN-112341389-A | Nitrogen-containing aromatic heterocycle substituted quinoline formamide derivative and application thereof | 浙江工业大学 | 2021-02-09 | — | — | CN | claimed |
| US-10401747-B1 | Undercoat layer for imaging device | XEROX CORPORATION (US) | 2019-09-03 | — | — | US | claimed |
| EP-2379558-B1 | NOVEL HETEROCYCLIC COMPOUNDS FOR USE AS METAP-2 INHIBITORS | MERCK PATENT GMBH (DE) | 2016-03-23 | — | — | EP | claimed |
| US-7981578-B2 | Additive containing photoconductors | XEROX CORPORATION (US) | 2011-07-19 | — | — | US | claimed |
| US-20090246660-A1 | ADDITIVE CONTAINING PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-10-01 | — | — | US | claimed |
| US-4009020-A | QUINOLINE-4-CARBOXYLIC ACID OR SALTS | AMCHEM PRODUCTS, INC. (US) | 1977-02-22 | — | — | US | claimed |
| EP-4724430-A1 | CONDENSED AZINES AS INHIBITORS OF CYCLIC ADP RIBOSE HYDROLASE | Flagship Pioneering Innovations VI, LLC (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4650002-A1 | ANILINE-BASED MODULATORS OF THE NUCLEAR RECEPTOR TLX (NR2E1) | Ludwig-Maximilians-Universität (DE) | 2025-11-19 | — | — | EP | disclosed |
| EP-4617270-A1 | ISOINDOLINONE DERIVATIVE HAVING QUINOLINE AMIDE STRUCTURE, AND USE THEREOF | Oncord Bio Inc (KR) | 2025-09-17 | — | — | EP | disclosed |
| US-20250214991-A1 | BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS | ONCOPIA THERAPEUTICS, INC. D/B/A/ SK LIFE SCIENCE LABS | 2025-07-03 | — | — | US | disclosed |
| CN-120152966-A | Isoindolinone derivative with quinolinamide structure and application thereof | 昂科德生物株式会社 | 2025-06-13 | — | — | CN | disclosed |
| CN-119585252-A | Bicyclic heteroaryl containing compounds as IKZF2 degrading agents | 翁科皮亚治疗公司和SK生命科学实验室 | 2025-03-07 | — | — | CN | disclosed |
| EP-0714393-A1 | THIAZOLES AS ANTIVIRAL | PFIZER INC. (US) | 1996-06-05 | — | — | EP | disclosed |
| WO-1995005378-A1 | ANTIVIRAL THIAZOLES | PFIZER INC. (US) | 1995-02-23 | — | — | WO | disclosed |
| EP-0123146-A2 | Compound with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom | CHIESI FARMACEUTICI S.p.A. (IT) | 1984-10-31 | — | — | EP | disclosed |
| US-4123440-A | ANTIARRHYTHMIA AND ANTIFIBRILLATORY AGENTS | BRISTOL-MYERS COMPANY (US) | 1978-10-31 | — | — | US | disclosed |
| US-4122273-A | PROPHYLACTIC, ANTIARRHYTHMIC | BRISTOL-MYERS COMPANY (US) | 1978-10-24 | — | — | US | disclosed |
| US-4009020-A | QUINOLINE-4-CARBOXYLIC ACID OR SALTS | AMCHEM PRODUCTS, INC. (US) | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214991-A1 | BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS | IKZF1, IKZF2, IKZF3 | KDM4E 647/4885HTT 1106/4885USP2 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.